Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
21,311
Total Claims
$1.5M
Drug Cost
1,306
Beneficiaries
$1,112
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-97%
Opioid rate vs peers
0.1% vs 2.6% avg
+4%
Cost per patient vs peers
$1,112 vs $1,068 avg
+42%
Brand preference vs peers
12.8% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
14
Opioid Claims
$151
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,717 claims · $1.1M
Generic: 18,481 claims · $362K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 383 | $278K |
| Rivaroxaban | 165 | $118K |
| Empagliflozin | 56 | $64K |
| Fluticasone/Umeclidin/Vilanter | 65 | $54K |
| Insulin Aspart | 48 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 97 | $32K |
| Budesonide/Formoterol Fumarate | 63 | $32K |
| Linaclotide | 39 | $28K |
| Varicella-Zoster Ge/As01b/Pf | 118 | $25K |
| Insulin Degludec | 30 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 21 | $23K |
| Insulin Degludec | 39 | $22K |
| Semaglutide | 17 | $19K |
| Levothyroxine Sodium | 1,358 | $17K |
| Exenatide Microspheres | 14 | $15K |
Prescribing Profile
Patient Profile
79
Avg Age
67%
Female
1.60
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data